Melanocyte stimulating hormone release inhibiting factor is an endogenous peptide fragment derived from cleavage of the hormone oxytocin, but having generally different actions in the body.
CAT No: R1833
CAS No:2002-44-0
Synonyms/Alias:2002-44-0;MELANOSTATIN;MIF-1;L-Prolyl-L-leucylglycinamide;Oxytocin C-terminal tripeptide;Pro-Leu-Gly-NH2;MIF-I;7-9-Oxytocin;Melanostatin I (ox);(S)-N-((S)-1-((2-Amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)pyrrolidine-2-carboxamide;Prolylleucylglycine amide;MSH-release inhibiting factor I;C13H24N4O3;(2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide;L-Prolyl-L-leucylglycylamide;Glycinamide, L-prolyl-L-leucyl-;L-Proline-L-leucine-glycine-amide;CHEMBL317488;3KY24B4Q62;(2S)-N-(carbamoylmethyl)-4-methyl-2-{[(2S)-pyrrolidin-2-yl]formamido}pentanamide;Pro-Leu-Gly amide;UNII-3KY24B4Q62;Prolyl-L-leucyl-glycinamide, L-;EINECS 217-902-7;L-pro-L-leu-gly-NH2;MELANOSTATIN MIF-I;SCHEMBL362530;MELANOSTATIN MIF-I [MI];DTXSID20173841;CHEBI:168693;NOOJLZTTWSNHOX-UWVGGRQHSA-N;MIF-I, (-)-;BBL033793;BDBM50060601;HB1874;MFCD00037866;MFCD08282654;STL372235;2-Pyrrolidinecarboxamide, N-(1-((carbamoylmethyl)carbamoyl)-3-methylbutyl)-;AKOS015955826;MSH RELEASE-INHIBITING FACTOR I;(2S)-N-(carbamoylmethyl)-4-methyl-2-[(2S)-pyrrolidin-2-ylformamido]pentanamide;(S)-N-((S)-1-(2-amino-2-oxoethylamino)-4-methyl-1-oxopentan-2-yl)pyrrolidine-2-carboxamide;DA-66890;FM109235;NS-04720;PD070730;HY-107663;CS-0029128;NS00026500;EN300-302728;6-((E)-3-Oxo-3-phenyl-propenyl)-1H-pyrimidine-2,4-dione;(E)-6-(3-oxo-3-phenylprop-1-enyl)pyrimidine-2,4(1H,3H)-dione;(S)-Pyrrolidine-2-carboxylic acid [(S)-1-(carbamoylmethyl-carbamoyl)-3-methyl-butyl]-amide;Pyrrolidine-2-carboxylic acid [1-(carbamoylmethyl-carbamoyl)-3-methyl-butyl]-amide;
Chemical Name:(2S)-N-[(2S)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carboxamide
3. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.